CNBC's Contessa Brewer looks ahead to what are likely to be next week's top business and financial stories. » Read More
By: Liz Moyer
Warren Buffett and Paul Singer are competing to buy Energy Future Holdings' Oncor. » Read More
Jack Ma-backed Yunfeng Financial Group said it will lead $1.7 billion acquisition of U.S.-based insurer MassMutual International's Asia unit » Read More
Michael Carr, co-head of Goldman Sachs' mergers and acquisitions unit, discusses the outlook for deals in 2016 and what roadblocks exist to sustained M&A activity.
Chicago Stock Exchange said on Friday an investor group led by China's Chongqing Casin Enterprise Group has agreed to buy the company.
Financial advisor Mitch Goldberg sees a big problem: too much cash, and too few good ideas for where to invest it in the stock market.
ArcelorMittal launched plans to raise $3 billion in fresh capital in a bid to reduce debt in the face of weak steel and mining sectors.
Antonin Jullier, global head of equity trading strategy at Citi, discusses the impact of the deal between Royal Dutch Shell and BG.
Goh Soo Jin, co-head of Platinum Equity, Singapore, explains why 2016 will be a great year for M&A activity.
S&P Capital IQ's Rich Peterson explains the uptick in recent M&A activity.
RBC Capital Markets lead tech analyst Mark Mahaney talks about what Yahoo and Netflix need to do to boost their businesses.
Lowe's Canada and Rona will create a retailer with 2015 pro-forma revenue of about $2.28 billion, Lowe's said on Wednesday.
Syngenta is to be bought by the Chinese state-owned company ChemChina for over $43 billion. CNBC caught up with the Swiss group's chairman to find out more.
The takeover of Syngenta by ChemChina does not amount to a Chinese nationalization of the Swiss agrichemicals giant.
From an anti-trust perspective, Syngenta doesn’t see any complications in the ChemChina deal, says its chairman explains.
Microsoft has acquired Swiftkey, a London-based artificial intelligence (AI) start-up that makes a predictive keyboard for smartphones.
Alexander Friedman, group CEO of GAM Holding AG, says ChemChina's acquisition of Syngenta could indicate confidence or the company can't find growth.
Michel Demaré, chairman of Syngenta, says the takeover deal with state-owned ChemChina is good value for shareholders.
CNBC's Julia Chatterley reports from Basel on Syngenta and the takeover deal by ChemChina, a Chinese state-owned company.
ChemChina is nearing a deal to take over Syngenta for around $42 billion, two people familiar with the matter told Reuters.
Acquisition of Portugal's Tivoli hotels gives entry points into new markets says Bill Heinecke, chairman and CEO of Minor International.
Herb Greenberg, Pacific Square Research managing partner, and the Power Lunch team talk about Twitter as an acquisition target.
M&A activity will be heating up in these sectors in 2016, despite market uncertainty, says Bob Rubino of Citizens Bank.
Get the best of CNBC in your inbox